Novel developments with selective, non-peptidic kappa-opioid receptor agonists
about
Kappa-opioid ligands in the study and treatment of mood disordersBipolar disorder: candidate drug targets.Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A30 years of dynorphins--new insights on their functions in neuropsychiatric diseasesPeptide kappa opioid receptor ligands: potential for drug development.Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test.Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalizationSelective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice.Pain control by immune-derived opioids.Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain.Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review.The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?The G-protein biased partial κ opioid receptor agonist 6'-GNTI blocks hippocampal paroxysmal discharges without inducing aversion.Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria.Cyclic endomorphin analogs in targeting opioid receptors to achieve pain relief.Regulation of gene transcription in bipolar disorders: Role of DNA methylation in the relationship between prodynorphin and brain derived neurotrophic factor.The Opioid System in Temporal Lobe Epilepsy: Functional Role and Therapeutic Potential.Highly Potent and Selective New Diphenethylamines Interacting with the κ-Opioid Receptor: Synthesis, Pharmacology, and Structure-Activity Relationships.Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia.Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171.Analgesics and Antipyretics
P2860
Q24657982-4A70BA8A-4831-4C2A-8B0C-1EE403FBC14BQ28751133-77B5E8B7-7061-4DCC-B280-5FF5E56A6804Q30467220-FAE0682D-27AC-4195-BF87-8E8F58AAF7CEQ30481450-63EB38B1-FDB2-4367-BCBF-F11BC6DEE652Q33442900-8E7E104A-74A2-469C-A9CF-7A290D872E26Q33728962-82A82C97-EE3B-4C01-A8B3-CAF1338E82ABQ33728974-6642B2FA-13C2-476C-915E-DDE5DF97A0F1Q33911524-8EDB5C48-FE9F-4A92-B42A-461604AD25C2Q33955138-5C4F38BA-854E-4B3A-9D21-CD96D8BCA02EQ34073200-6700EF03-291D-4964-8257-7DC87BC28749Q34766451-FB1D9AE6-10B3-41EA-B36F-87F4103ABBE3Q34948237-26731D3C-E048-46F3-B7C1-A412182162D6Q35752958-16868480-97D5-4AA2-A609-1855F641AA98Q36110480-8AF8E4F5-FA1A-4ACF-8C35-7BE10E25AC73Q36903392-AFB5A683-A02E-451A-994E-30874379988CQ37583184-8393AF29-AB0D-4BF8-8793-B5311806E529Q38297140-90E2875F-CEE0-4DE5-AF84-104F81457C94Q38613470-E45685CB-9D04-45B0-9BB5-FE492FB755C3Q38616839-B5914315-115A-42F1-BF86-ADFDEDE6DCECQ41722010-FBD287E1-FC90-4002-BB76-7B0E7B5FEFC9Q41979327-0BAA99A0-0BAD-4195-9873-DC2A6AA3280AQ44352076-4A643BC8-A259-4C9A-9D53-C63C5E66F7EAQ56113559-6A9D9553-9C17-4F23-AA07-62493D373C83
P2860
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@ast
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@en
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@nl
type
label
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@ast
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@en
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@nl
prefLabel
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@ast
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@en
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@nl
P2860
P1476
Novel developments with selective, non-peptidic kappa-opioid receptor agonists
@en
P2093
R Gottschlich
P2860
P304
P356
10.1517/13543784.6.10.1351
P407
P577
1997-10-01T00:00:00Z